Molecular targets of quercetin in cancer chemoprevention

CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources

Volumn 5, Issue , 2010, Pages

  Granado Serrano, Ana Belén ^a   Ramos, Sonia ^a  

^a INSTITUTO DEL FRÍO CSIC   (Spain)

Author keywords

Apoptosis; Cancer chemoprevention; Cell cycle; Inflammation; Proliferation survival pathways; Quercetin

Indexed keywords

EID: 80052501183     PISSN: None     EISSN: 17498848     Source Type: Journal    
DOI: 10.1079/PAVSNNR20105035     Document Type: Review

References (174)

1. Manson M. Cancer prevention - the potential for diet to modulate molecular signaling. Trends in Molecular Medicine 2003;9:11-8. (Pubitemid 36139250)
2. Bravo L. Polyphenols: chemistry, dietary sources, metabolism and nutritional significance. Nutrition Reviews 1998;56:317-33. (Pubitemid 28532456)
3. Ramos S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. Journal of Nutritional Biochemistry 2007;18:427-42. (Pubitemid 46874924)
4. Watson W, Cai J, Jones D. Diet and apoptosis. Annual Review of Nutrition 2000;108:153-64.
5. Wenzel U, Kuntz S, Brendel M, Daniel H. Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Research 2000;60:3823-31. (Pubitemid 32204574)
6. Yang C, Landau J, Huang M, Newmark H. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annual Review of Nutrition 2001;21:381-97.
7. Ramos S. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Molecular Nutrition and Food Research 2008;52:507-26.
8. Alia M, Mateos R, Ramos S, Lecumberri E, Bravo L, Goya L. Influence of quercetin and rutin on growth and antioxidant defense system of a human hepatoma cell line (HepG2). European Journal of Nutrition 2006;45:19-28. (Pubitemid 43221280)
9. Alía M, Ramos S, Mateos R, Granado-Serrano A, Bravo L, Goya L. Quercetin protects human hepatoma cell line (HepG2) against oxidative stress induced by tertbutyl hydroperoxide. Toxicology and Appllied Pharmacology 2006;212:110-8.
10. Granado-Serrano A, Martín M, Bravo L, Goya L, Ramos S. Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/Akt and ERK pathways in a human hepatoma cell line (HepG2). Journal of Nutrition 2006;136:2715-21. (Pubitemid 44771763)
11. Granado-Serrano A, Martin M, Bravo L, Goya L, Ramos S. Time-course regulation of quercetin on cell survival/proliferation pathways in human hepatoma cells. Molecular Nutrition and Food Research 2008;52:457-64.
12. Ramos S, Alia M, Bravo L, Goya L. Comparative effects of food-derived polyphenols on the viability and apoptosis of a human hepatoma cell line (HepG2). Journal of Agriculture and Food Chemistry 2005;53:1271-80. (Pubitemid 40270427)
13. Manach C, Scalbert A, Morand C, Remesy C, Jimenez L. Polyphenols: food sources and bioavailability. American Journal of Clinical Nutrition 2004;79:727-47. (Pubitemid 41103873)
14. Manach C, Williamson G, Morand C, Scalbert A, Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. American Journal of Clinical Nutrition 2005;81 Suppl.: 230S-42S.
15. Manach C, Williamson G. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. American Journal of Clinical Nutrition 2005;81 Suppl.: 243S-55S.
16. Hertog M G L, Hollman P C H, Katan MB, Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutrition and Cancer 1993;20:21-9. (Pubitemid 23225364)
17. Mogren LM, Olsson ME, Gertsson UE. Quercetin content in field-cured onions (Allium cepa L.): effects of cultivar, lifting time, and nitrogen fertilizer level. Journal of Agriculture and Food Chemistry 2006;54:6185-91. (Pubitemid 44367581)
18. Price KR, Bacon JR, Rhodes M J C. Effect of storage and domestic processing on the content and composition of flavonol glucosides in onion (Allium cepa). Journal of Agriculture and Food Chemistry 1997;45:938-42. (Pubitemid 127483732)
19. Prakash D, Singh B, Upadhyay G. Antioxidant and free radical scavenging activities of phenols from onion (Allium cepa). Food and Chemical Toxicology 2007;102:1389-93. (Pubitemid 46176462)
20. Hirota S, Shimoda T, Takahama U. Tissue and spatial distribution of flavonol and peroxidase in onion bulbs and stability of flavonol glucosides during boiling of the scales. Journal of Agriculture and Food Chemistry 1998;46:3497-502. (Pubitemid 128488156)
21. Nemeth K, Piskula MK. Food content, processing, absorption and metabolism of onion flavonoids. Critical Reviews in Food Science and Nutrition 2007;47:397-409. (Pubitemid 46676538)
22. Slimestad R, Fossen T, Vagen IM. Onions: a source of unique dietary flavonoids. Journal of Agriculture and Food Chemistry 2007;55:10067-80.
23. Rohn S, Buchner N, Driemel G, Rauser M, Kroh LW. Thermal degradation of onion quercetin glucosides under roasting conditions. Journal of Agriculture and Food Chemistry 2007;55:1568-73.
24. Tapiero H, Tew KD, Ba GN, Mathe G. Polyphenols: do they play a role in the prevention of human pathologies? Biomedicine and Pharmacotherapy 2002;56:200-7. (Pubitemid 34628383)
25. Watjen W, Michels G, Steffan B, Niering P, Chovolou Y, Kampkotter A, et al. Low concentrations of flavonoids are protective in rat H4IIE cells whereas high concentrations cause DNA damage and apoptosis. Journal of Nutrition 2005;135:525-31. (Pubitemid 40365213)
26. Csokay B, Prajda N, Weber G, Olah E. Molecular mechanisms in the antiproliferative action of quercetin. Life Sciences 1997;60:2157-63. (Pubitemid 27244397)
27. Chi C, Chang Y, Ou Y, Hsieh C, Lui Y, Peng F, et al. Effect of quercetin on the in vitro and in vivo growth of mouse hepatoma cells. Oncology Research 1997;4:1021-4. (Pubitemid 27357232)
28. Mouria M, Gukovskaya A, Jung Y, Buechler P, Hines O, Reber H, et al. Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome c release and apoptosis. International Journal of Cancer 2002;98:761-9. (Pubitemid 34225629)
29. Nguyen T, Tran E, Nguyen T, Do P, Huynh T, Huynh H. The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis 2004;25:647-59. (Pubitemid 38618516)
30. Harwood M, Danielewska-Nikiel B, Borzelleca JF, Flamm GW, Williams GM, Lines TC. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food and Chemical Toxicology 2007;45:2179-205. (Pubitemid 47451573)
31. Moon J-H, Nakata R, Oshima S, Inakuma T, Terao J. Accumulation of quercetin conjugates in blood plasma after the short-term ingestion of onion by women. American Journal of Physiology Regulatory Integrative and Comparative Physiology 2000;279:R461-7.
32. Bieger J, Cermak R, Blank R, de Boer V, Hollman P, Kamphues J, et al. Tissue distribution of quercetin in pigs after long-term dietary supplementation. Journal of Nutrition 2008;138:1417-20.
33. Spencer J, Rice-Evans C, Williams R. Modulation of pro-survival Akt/protein kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. Journal of Biological Chemistry 2003;278:34783-93. (Pubitemid 37102237)
34. Williamson G, Baron D, Shimoi K, Terao J. In vitro biological properties of flavonoid conjugates found in vivo. Free Radical Research 2005;39:457-69. (Pubitemid 40711878)
35. Shimoi K, Saka N, Nozawa R, Sato M, Amano I. Deconjugation of a flavonoid, luteolin monoglucuronide, during inflammation. Drug Metabolism and Disposition 2001;29:1521-4. (Pubitemid 33111582)
36. Hanahan D, Weinberg R. The hallmarks of cancer. Cell 2000;100:57-70. (Pubitemid 30046295)
37. Surh Y-J. Cancer chemoprevention with dietary phytochemicals. Nature Reviews Cancer 2003;3:768-80. (Pubitemid 37328815)
38. Ramos S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. The Journal of Nutritional Biochemistry 2007;18:427-42. (Pubitemid 46874924)
39. Aalinkeel R, Bindukumar B, Reynolds J, Sykes D, Mahajan S, Chadha K, et al. The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat shock protein 90. The Prostate 2008;68:1773-89.
40. Chowdhury S, Kishino K, Satoh R, Hashimoto K, Kikuchi H, Nishikawa H, et al. Tumor-specificity and apoptosis-inducing activity of stilbenes and flavonoids. Anticancer Research 2005;25:2055-63. (Pubitemid 40904604)
41. Jakubowicz-Gil J, Rzeski W, Zdzisinska B, Piersiak T, Weiksza K, Glowniak K, et al. Different sensitivity of neurons and neuroblastoma cells to quercetin treatment. Acta Neurobiologiae Experimentalis 2008;68:463-76.
42. Lee D-H, Szczepanski M, Lee Y. Role of Bax in quercetin-induced apoptosis in human prostate cancer cells. Biochemical Pharmacology 2008;75:2345-55.
43. Nair H, Rao K, Aalinkeel R, Mahajan S, Chawda R, Schwartz S. Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clinical and Diagnostic Laboratory Immunology 2004;11:63-9. (Pubitemid 38090653)
44. Feskanich D, Ziegler R, Michaud D, Giovannucci E, Speizer F, Willett W, et al. Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women. Journal of National Cancer Institute 2000;92:1812-23.
45. Michels K, Giovannucci E, Chan A, Singhania R, Fuchs C, Willett W. Fruit and vegetable consumption and colorectal adenomas in the Nurses' Health Study. Cancer Research 2006;66:3942-53.
46. Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, et al. Flavonoid intake and risk of chronic diseases. American Journal of Clinical Nutrition 2002;76:560-8. (Pubitemid 34920833)
47. Garcia-Closas R, Gonzalez C, Agudo A, Riboli E. Intake of specific carotenoids and flavonoids and the risk of gastric cancer in Spain. Cancer Causes and Control 1999;10:71-5. (Pubitemid 29134755)
48. Le Marchand L, Murphy S, Hankin J, Wilkens L, Kolonel L. Intake of flavonoids and lung cancer. Journal of National Cancer Institute 2000;92:154-60. (Pubitemid 30089873)
49. Garcia R, Gonzalez C, Agudo A, Riboli E. High intake of specific carotenoids and flavonoids does not reduce the risk of bladder cancer. Nutrition and Cancer 1999;35:212-4. (Pubitemid 30115135)
50. Garcia-Closas R, Agudo A, Gonzalez C, Riboli E. Intake of specific carotenoids and flavonoids and the risk of lung cancer in women in Barcelona, Spain. Nutrition and Cancer 1998;32:154-8. (Pubitemid 29081402)
51. Ferry D, Smith A, Malkhandi J, Fyfe D, de Takats P, Anderson D, et al. Phase I clinical trials of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clinical Cancer Research 1996;2:659-68. (Pubitemid 26133468)
52. Mulholland P, Ferry D, Anderson D, Hussain S, Young A, Cook J, et al. Pre-clinical and clinical study of QC12, a watersoluble, pro-drug of quercetin. Annals of Oncology 2001;12:245-8. (Pubitemid 32223876)
53. Ferry D, Anderson M, Beddows K, Mayer P, Price L, Jankowski J. Phase II trial of gefitinib (ZD1839) in advanced adenocarcinoma of the oesophagus incorporating biopsy before and after gefitinib. Journal of Clinical Oncology 2004;22:4021.
54. Middleton EJ, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacological Reviews 2000;52:673-751.
55. Sonee M, Sum T, Wang C, Mukherjee S. The soy isoflavone, genistein, protects human cortical neuronal cells from oxidative stress. Neurotoxicology 2004;25:885-91. (Pubitemid 39013337)
56. Nakagawa H, Hasumi K, Woo J, Nagai K, Wachi M. Generation of hydrogen peroxide primarily contributes to the induction of Fe (II)-dependent apoptosis in Jurkat cells by (7)-epigallocatechin gallate. Carcinogenesis 2004;25:1567-74. (Pubitemid 39214298)
57. Choi Y-J, Kang J-S, Park J, Lee Y-J, Choi J-S, Kang Y-H. Polyphenolic flavonoids differ in their antiapoptotic efficacy in hydrogen peroxide-treated human vascular endothelial cells. Journal of Nutrition 2003;133:985-91. (Pubitemid 36407114)
58. Ferraresi R, Troiano L, Roat E, Lugli E, Nemes E, Nasi M, et al. Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin. Free Radical Research 2005;39:1249-58. (Pubitemid 41601428)
59. Van der Woude H, Gliszczynska-Swiglo A, Struijs K, Smeets A, Alink G, Rietjens I. Biphasic modulation of cell proliferation by quercetin at concentrations physiologically relevant in humans. Cancer Letters 2003;200:41-7. (Pubitemid 37222357)
60. Schwarz D, Roots I. In vitro assessment of inhibition by natural polyphenols of metabolic activation of procarcinogens by human CYP1A1. Biochemical and Biophysical Research Communications 2003;303:902-7. (Pubitemid 36384940)
61. Maliakal P, Wanwimolruk S. Effect of herbal teas on hepatic drug metabolizing enzymes in rats. Journal of Pharmacy and Pharmacology 2001;53:1323-9. (Pubitemid 32982248)
62. Rodgers E, Grant M. The effect of the flavonoids, quercetin, myricetin and epicatechin on the growth and enzyme activities of MCF7 human breast cancer cells. Chemico-Biological Interactions 1998;116:213-28. (Pubitemid 28543195)
63. Schwarz D, Kisselev P, Roots I. CYP1A1 genotype-selective inhibition of benzo[a]pyrene activation by quercetin. European Journal of Cancer 2005;41:151-8. (Pubitemid 40029668)
64. Flaveny CA, Murray IA, Chiaro CR, Perdew GH. Ligand selectivity and gene regulation by the human Aryl Hydrocarbon Receptor in transgenic mice. Molecular Pharmacology 2009;75:1412-20.
65. Ashida H, Fukuda I, Yamashita T, Kanazawa K. Flavones and flavonols at dietary levels inhibit a transformation of aryl hydrocarbon receptor induced by dioxin. FEBS Letters 2000;476:213-7. (Pubitemid 30410820)
66. Fukuda I, Mukai R, Kawase M, Yoshida K, Ashida H. Interaction between the aryl hydrocarbon receptor and its antagonists, flavonoids. Biochemical and Biophysical Research Communications 2007;359:822-7. (Pubitemid 46899026)
67. van der Heiden E, Bechoux N, Muller M, Sergent T, Schneider Y-J, Larondelle Y, et al. Food flavonoid aryl hydrocarbon receptor-mediated agonistic/antagonistic/synergic activities in human and rat reporter gene assays. Analytica Chimica Acta 2009;637:337-45.
68. Odbayar T-O, Kimura T, Tsushida T, Ide T. Isoenzyme-specific up-regulation of glutathione transferase and aldo-keto reductase mRNA expression by dietary quercetin in rat liver. Molecular and Cellular Biochemistry 2009;325:121-30.
69. Gerhauser C, Klimo K, Heiss E, Neumann I, Gamal-Eldeen A, Knauft J, et al. Mechanism-based in vitro screening of potential cancer chemopreventive agents. Mutation Research 2003;523-524:163-72. (Pubitemid 36293243)
70. Valerio LJ, Kepa J, Pickwell G, Quattrochi L. Induction of human NAD (P) H:quinone oxidoreductase (NQO1) gene expression by the flavonol quercetin. Toxicology Letters 2001;119:49-57. (Pubitemid 32244058)
71. Zheng Q, Hirose Y, Yoshimi N, Murakami A, Koshimizu M, Ohigashi H, et al. Further investigation of the modifying effect of various chemopreventive agents on apoptosis and cell proliferation in human colon cancer cells. Journal of Cancer Research and Clinical Oncology 2002;128:539-46. (Pubitemid 35244929)
72. Scharf G, Prustomersky S, Knasmuller S, Schulte-Hermann R, Huber W. Enhancement of glutathione and g-glutamylcysteine synthetase, the rate limiting enzyme of glutathione synthesis, by chemoprotective plant-derived food and beverage components in the human hepatoma cell line HepG2. Nutrition and Cancer 2003;45:74-83. (Pubitemid 36736894)
73. Rohrdanz E, Bittner A, Tran-Thi Q-H, Kahl R. The effect of quercetin on the mRNA expression of different antioxidant enzymes in hepatoma cells. Archives of Toxicology 2003;77:506-10. (Pubitemid 37255470)
74. Hayes J, McMahon M. Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention. Cancer Letters 2001;174:103-13. (Pubitemid 33026113)
75. Kweon M, Adhami V, Lee J, Mukhtar H. Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate. Journal of Biological Chemistry 2006;281:33761-72. (Pubitemid 46036754)
76. Lee J, Surh Y. Nrf2 as a novel molecular target for chemoprevention. Cancer Letters 2005;224:171-84. (Pubitemid 40725839)
77. Tanigawa S, Fujii M, Hou D. Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin. Free Radical Biology and Medicine 2007;42:1690-703. (Pubitemid 46617147)
78. Yao P, Nussler A, Liu L, Hao L, Song F, Schirmeier A, et al. Quercetin protects human hepatocytes from ethanol-derived oxidative stress by inducing heme oxygenase-1 via the MAPK/Nrf2 pathways. Journal of Hepatology 2007;47:253-61. (Pubitemid 47023137)
79. Jeong J-H, An J, Kwon Y, Rhee J, Lee Y. Effects of low dose quercetin: cancer cell-specific inhibition of cell cycle progression. Journal of Cellular Biochemistry 2009;106:73-82.
80. Lee Y-K, Park S, Kim Y-M, Lee W, Park O. AMP kinase/cyclooxygenase-2 pathway regulates proliferation and apoptosis of cancer cells treated with quercetin. Experimental and Molecular Medicine 2009;41:201-7.
81. Yang J-H, Hsia T, Kuo H-M, Lee Chao P-D, Chou C-C, Wei Y-H, et al. Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis. Drug Metabolism and Disposition 2006;34:296-304. (Pubitemid 43145031)
82. Brisdelli F, Coccia C, Cinque B, Cifone M, Bozzi A. Induction of apoptosis by quercetin: different response of human chronic myeloid (K562) and acute lymphoblastic (HSB-2) leukemia cells. Molecular and Cellular Biochemistry 2007;296:137-49.
83. Choi E, Bae S, Ahn W. Antiproliferative effects of quercetin through cell cycle arrest and apoptosis in human breast cancer MDA-MB-453 cells. Archives of Pharmacal Research 2008;31:1281-5.
84. Shan B, Wang M, Li R. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Cancer Investigation 2009;27:604-12.
85. Tan J, Wang B, Zhua L. Regulation of survivin and Bcl-2 in HepG2 cell apoptosis induced by quercetin. Chemistry and Biodiversity 2009;6:1101-10.
86. Zhang Q, Zhao X-H, Wang Z-J. Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis. Food Chemistry and Toxicology 2008;46:2042-53.
87. Tanigawa S, Fujii M, Hou D-X. Stabilization of p53 is involved in quercetin-induced cell cycle arrest and apoptosis in HepG2 cells. Bioscience Biotechnology and Biochemistry 2008;72:797-804. (Pubitemid 351463685)
88. Vijayababu M, Kanagaraj P, Arunkumar A, Ilangovan R, Aruldhas M, Arunakaran J. Quercetin-induced growth inhibition and cell death in prostatic carcinoma cells (PC-3) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression. Journal of Cancer Research and Clinical Oncology 2005;131:765-71. (Pubitemid 41577954)
89. Mertens-Talcott S, Percival S. Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Letters 2005;218:141-51. (Pubitemid 40164715)
90. Huang S-L, Hsu C-L, Yen G-C. Growth inhibitory effect of quercetin on SW 872 human liposarcoma cells. Life Sciences 2006;79:203-9. (Pubitemid 43737061)
91. Kang J, Kim J, Song K, Kim S, Yoon J-H, Kim K-S. Kaempferol and quercetin, components of Ginkgo biloba extract (EGb 761), induce caspase-3-dependent apoptosis in oral cavity cancer cells. Phytotherapy Research 2010;24 Suppl 1:S77-82.
92. Lim J-H, Park J-W, Min D, Chang J-S, Lee Y, Park Y, et al. NAG-1 up-regulation mediated by EGR-1 and p53 is critical for quercetin-induced apoptosis in HCT116 colon carcinoma cells. Apoptosis 2007;12:411-21. (Pubitemid 46169920)
93. Tan W, Lin L, Li M, Zhang Y, Tong Y, Xiao D, et al. Quercetin, a dietary-derived flavonoid, possesses antiangiogenic potential. European Journal of Pharmacology 2003;459:255-62. (Pubitemid 36078329)
94. Wang I, Lin-Shiau S, Lin J. Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. European Journal of Cancer 1999;35:1517-25. (Pubitemid 29454650)
95. Van Erk M, Roepman P, van der Lende T, Stierum R, Aarts J, van Bladeren P, et al. Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro. European Journal of Nutrition 2005;44:143-56. (Pubitemid 40585513)
96. Russo A, Acquaviva R, Campisi A, Sorrenti V, Di Giacomo C, Virgata G, et al. Bioflavonoids as antiradicals, antioxidants and DNA cleavage protectors. Cell Biology and Toxicology 2000;16:91-8. (Pubitemid 30451544)
97. Kim E, Choi C, Park J, Kang S, Kim Y. Underlying mechanism of quercetin-induced cell death in human glioma cells. Neurochemical Research 2008;33:971-9.
98. Yoshizumi M, Tsuchiya K, Kirima K, Kyaw M, Suzaki Y, Tamak IT. Quercetin inhibits Shc-and phosphatidylinositol 3-kinase-mediated c-Jun. N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells. Molecular Pharmacology 2001;60:656-65. (Pubitemid 32900246)
99. Psahoulia F, Drosopoulos K, Doubravska L, Andera L, Pintzas A. Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts. Molecular Cancer Therapeutics 2007;6:2591-99. (Pubitemid 47480425)
100. Chen D, Daniel K, Chen M, Kuhn D, Landis-Piwowar K, Dou Q. Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells. Biochemical Pharmacology 2005;69:1421-32. (Pubitemid 40602442)
101. Kim W, Bang M, Kim E, Kang N, Jung K, Cho H, et al. Quercetin decreases the expression of ErbB2 and ErbB3 proteins in HT-29 human colon cancer cells. The Journal of Nutrition and Biochemistry 2005;16:155-62. (Pubitemid 40312168)
102. Kaneuchi M, Sasaki M, Tanaka Y, Sakuragi N, Fujimoto S, Dahiya R. Quercetin regulates growth of Ishikawa cells through the suppression of EGF and cyclin D1. International Journal of Oncology 2003;22:159-64.
103. Zhang X-M, Chen J, Xia Y-G, Xu Q. Apoptosis of murine melanoma B16-BL6 cells induced by quercetin targeting mitochondria, inhibiting expression of PKC-alpha and translocating PKC-delta. Cancer Chemotherapy and Pharmacology 2005;55:251-62. (Pubitemid 40142890)
104. Chinnathambi S, Tomanek-Chalkley A, Bickenbach JR. HSP70 and EndoG modulate cell death by heat in human skin keratinocytes in vitro. Cells Tissues Organs 2008;187:131-40. (Pubitemid 351252948)
105. Ishikawa Y, Kitamura M. Anti-apoptotic effect of quercetin: intervention in the JNK-and ERK-mediated apoptotic pathways. Kidney International 2000;58:1078-87.
106. Marone M, D'Andrilli G, Ferlini C, Chatterjee S, Scambia G. Quercetin abrogates taxol-mediated signaling by inhibiting multiple kinases. Experimental Cell Research 2001;270:1-12. (Pubitemid 32978084)
107. Nicholson K, Anderson N. The protein kinase B/Akt signalling pathway in human malignancy. Cellular Signalling 2002;14:381-95. (Pubitemid 34214843)
108. Ballif B, Blenis J. Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth and Differentiation 2001;12:397-408. (Pubitemid 32762689)
109. Son Y. Quercetin accelerates TNF-alpha-induced apoptosis of MC3T3-E1 osteoblastic cells through caspase-dependent and JNK-mediated pathways. European Journal of Pharmacology 2008;579:26-33.
110. Xavier C, Lima C, Preto A, Seruca R, Fernandes-Ferreira M, Pereira-Wilson C. Luteolin, quercetin and ursolic acid are potent inhibitors of proliferation and inducers of apoptosis in both KRAS and BRAF mutated human colorectal cancer cells. Cancer Letters 2009;281:162-70.
111. Galluzzo P, Martini C, Bulzomi P, Leone S, Bolli A, Pallottini V, et al. Quercetin-induced apoptotic cascade in cancer cells: antioxidant versus estrogen receptor alpha-dependent mechanisms. Molecular Nutrition and Food Research 2009;53:699-708.
112. Elattar T, Virji A. The inhibitory effect of curcumin, genistein, quercetin and cisplatin on the growth of oral cancer cells in vitro. Anticancer Research 2000;20:1733-8. (Pubitemid 30628195)
113. Robaszkiewicz A, Balcerczyk A, Bartosz G. Antioxidative and prooxidative effects of quercetin on A549 cells. Cell Biology International 2007;31:1245-50. (Pubitemid 47030992)
114. Ramos AM, Aller P. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines. Biochemical Pharmacology 2008;75:1912-23.
115. Yu R, Jiao J, Duh J, Gudehithlu K, Tan T, Kong A. Activation of mitogen-activated protein kinases by green tea polyphenols: potential signaling pathways in the regulation of antioxidant-responsive element-mediated Phase II enzyme gene expression. Carcinogenesis 1997;18:451-56. (Pubitemid 28132441)
116. Kong A, Yu R, Chen C, Mandlekar S, Primiano T. Signal transduction events elicited by natural products: role of MAPK and caspase pathways in homeostatic response and induction of apoptosis. Archives of Pharmacal Research 2000;23:1-16.
117. Donnini S, Finetti F, Lusini L, Morbidelli L, Cheynier V, Barron D, et al. Divergent effects of quercetin conjugates on angiogenesis. British Journal of Nutrition 2006;95:1016-23. (Pubitemid 43805391)
118. Kern M, Tjaden Z, Ngiewih Y, Puppel N, Will F, Dietrich H, et al. Inhibitors of the epidermal growth factor receptor in apple juice extract. Molecular Nutrition and Food Research 2005;49:317-28. (Pubitemid 40545524)
119. Fridrich D, Teller N, Esselen M, Pahlke G, Marko D. Comparison of delphinidin, quercetin and (-)-epigallocatechin-3-gallate as inhibitors of the EGFR and the ErbB2 receptor phosphorylation. Molecular Nutrition and Food Research 2008;52:815-22.
120. Huynh H, Nguyen T, Chan E, Tran E. Inhibition of ErbB-2 and ErbB-3 expression by quercetin prevents transforming growth factor alpha (TGF-alpha) - and epidermal growth factor (EGF)-induced human PC-3 prostate cancer cell proliferation. International Journal of Oncology 2003;23:821-29.
121. Huang Y, Hwang J, Lee P, Ke F, Huang J, Huang C, et al. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. British Journal of Pharmacology 1999;128:999-1010. (Pubitemid 29512033)
122. Lee L, Huang Y, Hwang J, Lee A, Ke F, Huang C, et al. Transinactivation of the epidermal growth factor receptor tyrosine kinase and focal adhesion kinase phosphorylation by dietary flavonoids: effect on invasive potential of human carcinoma cells. Biochemical Pharmacology 2004;67:2103-14. (Pubitemid 38595491)
123. Raspaglio G, Ferrandina G, Ferlini C, Scambia G, Ranelletti FO. Epidermal growth factor-responsive laryngeal squamous cancer cell line Hep2 is more sensitive than unresponsive CO-K3 one to quercetin and tamoxifen apoptotic effects. Oncology Research 2003;14:83-91. (Pubitemid 38166337)
124. Jeong J-H, An JY, Kwon YT, Li L-Y, Lee YJ. Quercetininduced ubiquitination and down-regulation of Her-2/neu. Journal of Cellular Biochemistry 2008;105:585-95.
125. van der Woude H, Ter Veld M G R, Jacobs N, van der Saag PT, Murk AJ, Rietjens I M C M. The stimulation of cell proliferation by quercetin is mediated by the estrogen receptor. Molecular Nutrition and Food Research 2005;49:763-71. (Pubitemid 41188584)
126. Maggiolini M, Bonofiglio D, Marsico S, Panno M, Cenni B, Picard D, et al. Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Molecular Pharmacology 2001;60:595-602. (Pubitemid 32782656)
127. Perkins N, Gilmore T. Good cop, bad cop: the different faces of NF-kB. Cell Death and Differentiation 2006;1:1-14.
128. Garcia-Mediavilla V, Crespo I, Collado P, Esteller A, Sanchez-Campos S, et al. The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and relative C-protein, and down-regulation of the nuclear factor-kappaB pathway in Chang liver cells. European Journal of Pharmacology 2007;557:221-29. (Pubitemid 46186282)
129. Kobuchi H, Roy S, Sen C, Nguyen H, Packer L. Quercetin inhibits inducible ICAM-1 expression in human endothelial cells through the JNK pathway. American Journal of Physiology (Cell Physiol) 1999;277:C403-11. (Pubitemid 29458175)
130. Lee J, Kim J, Park J, Chung G, Jang Y. The antioxidant, rather than prooxidant, activities of quercetin on normal cells: quercetin protects mouse thymocytes from glucose oxidasemediated apoptosis. Experimental Cell Research 2003;291:386-97. (Pubitemid 37485726)
131. Martinez-Florez S, Gutierrez-Fernandez B, Sanchez-Campos S, Gonzalez-Gallego J, Tunon M. Quercetin attenuates nuclear factor-kB activation and nitric oxide production in interleukin-1b-activated rat hepatocyte. Journal of Nutrition 2005;135:1359-65. (Pubitemid 40799596)
132. Wu C-H, Wu C-F, Huang H-W, Jao Y-C, Yen G-C. Naturally occurring flavonoids attenuate high glucose-induced expression of proinflammatory cytokines in human monocytic THP-1 cells. Molecular Nutrition and Food Research 2009;53:984-95.
133. Hamalainen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators of Inflammation 2007; ID 45673.
134. Katula K, McCain J, Radewicz A. Relative ability of dietary compounds to modulate nuclear factor-kappaB activity as assessed in a cell-based reporter system. Journal of Medicinal Food 2005;8:269-74. (Pubitemid 41008995)
135. Nair M, Mahajan S, Reynolds J, Aalinkeel R, Nair H, Schwartz S, et al. The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-kB system. Clinical and Vaccine Immunology 2006;13:319-28.
136. Lee S, Kim Y-J, Kwon S, Lee Y, Choi S, Park J, et al. Inhibitory effects of flavonoids on TNF-a-induced IL-8 gene expression in HEK 293 cells. BMB reports 2009;42:265-70.
137. Comalada M, Camuesco D, Sierra S, Ballester I, Xaus J, Gálvez J, et al. In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kB pathway. European Journal of Immunology 2005;35:584-92. (Pubitemid 40331335)
138. Pastore S, Potapovich A, Kostyuk V, Mariani V, Lulli D, De Luca C, et al. Plant polyphenols effectively protect HaCaT cells from ultraviolet C-triggered necrosis and suppress inflammatory chemokine expression. Annals of the New York Academy of Sciences 2009;1171:305-13.
139. Cho SY, Park SJ, Kwon MJ, Jeong TS, Bok SH, Choi WY, et al. Quercetin suppresses proinflammatory cytokines production through MAP kinases and NF-kappaB pathway in lipopolysaccharide-stimulated macrophage. Molecular and Cellular Biochemistry 2003;243:395-406.
140. Thun M, Henley J, Gansler T. Inflammation and cancer: an epidemioloical perspective. Novartis Foundation Symposium 2004;256:6-28.
141. Lu H, Ouyang W, Huang C. Inflammation, a key event in cancer development. Molecular Cancer Research 2006;4:1-13.
142. O'Leary K, de Pascual-Tereasa S, Needs P, Bao Y-P, O'Brien N, Williamson G. Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutation Research 2004;551:245-54. (Pubitemid 38833512)
143. Warren C, Paulhill K, Davidson Jr LL, Taddeo S, Hong M, Carroll R, et al. Quercetin may suppress rat aberrant crypt foci formation by suppressing inflammatory mediators that influence proliferation and apoptosis. Journal of Nutrition 2009;139:101-5.
144. Chen T-J, Shen S-C, Lin H-Y, Chien L-L, Chend Y-C. Lipopolysaccharide enhancement of 12-O-tetradecanoylphorbol 13-acetate-mediated transformation in rat glioma C6, accompanied by induction of inducible nitric oxide synthase. Toxicology Letters 2004;147:1-13. (Pubitemid 38045314)
145. Ying B, Yang T, Song X, Hu X, Fan H, Lu X, et al. Quercetin inhibits IL-1 beta-induced ICAM-1 expression in pulmonary epithelial cell line A549 through the MAPK pathways. Molecular Biology Report 2009;36:1825-32.
146. Chen C-C, Chow M-P, Huang W-C, Lin Y-C, Chang Y-J. Flavonoids inhibit tumor necrosis factor-alpha-induced up-regulation of intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells through activator protein-1 and nuclear factor-kB: structure-activity relationships. Molecular Pharmacology 2004;66:683-93. (Pubitemid 39329268)
147. Barth S, Faehndrich C, Bub A, Watzl B, Will F, Dietrich H, et al. Cloudy apple juice is more effective than apple polyphenols and an apple juice derived cloud fraction in a rat model of colon carcinogenesis. Journal of Agricultural and Food Chemistry 2007;55:1181-7.
148. Dihal A, van der Woude H, Hendriksen P, Charif H, Dekker L, Jsselstijn L, et al. Transcriptome and proteome profiling of colon mucosa from quercetin fed F344 rats point to tumor preventive mechanisms, increased mitochondrial fatty acid degradation and decreased glycolysis. Proteomics 2008;8:45-61.
149. Dolara P, Luceri C, de Filippo C, Femia A, Giovannelli L, Caderni G, et al. Red wine polyphenols influence carcinogenesis, intestinal microflora, oxidative damage and gene expression profiles of colonic mucosa in F344 rats. Mutation Research 2005;59:237-46. (Pubitemid 41654852)
150. Gee J, Hara H, Johnson I. Suppression of intestinal crypt cell proliferation and aberrant crypt foci by dietary quercetin in rats. Nutrition Cancer 2002;43:193-201. (Pubitemid 36134094)
151. Gosse F, Guyot S, Roussi S, Lobstein A, Fischer B, Seiler N, et al. Chemopreventive properties of apple procyanidins on human colon cancer-derived metastatic SW620 cells and in a rat model of colon carcinogenesis. Carcinogenesis 2005;26:1291-5. (Pubitemid 41417908)
152. Tao L, Kramer P, Wang W, Yang S, Lubet R, Steele V, et al. Altered expression of c-myc, p16 and p27 in rat colon tumors and its reversal by short-term treatment with chemopreventive agents. Carcinogenesis 2002;23:1447-54. (Pubitemid 35012425)
153. Volate S, Davenport D, Muga S, Wargovich M. Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis 2005;26:1450-6. (Pubitemid 41417889)
154. Yang K, Lamprecht S, Liu Y, Shinozaki H, Fan K, Leung D, et al. Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon. Carcinogenesis 2000;21:1655-60.
155. De S, Chakraborty J, Chakraborty R, Das S. Chemopreventive activity of quercetin during carcinogenesis in cervix uteri in mice. Phytotherapy Research 2000;14:347-51. (Pubitemid 30655520)
156. Kamaraj S, Vinodhkumar R, Anandakumar P, Jagan S, Ramakrishnan G, Devaki T. The effects of quercetin on antioxidant status and tumor markers in the lung and serum of mice treated with benzo (a) pyrene. Biological and Pharmceutical Bulletin 2007;30:2268-73. (Pubitemid 350223724)
157. Singh B, Singh B, Sarma B, Singh H. Potential chemoprevention of N-nitrosodiethylamine-induced hepatocarcinogenesis by polyphenolics from Acacia nilotica bark. Chemico-Biological Interactions 2009;181:20-8.
158. Dechsupa S, Kothan S, Vergote J, Leger G, Martineau A, Beranger S, et al. Quercetin, siamois 1 and siamois 2 induce apoptosis in human breast cancer MDA-MB-435 cells xenograft in vivo. Cancer Biology and Therapy 2007;6:56-61. (Pubitemid 46294176)
159. Orsolic N, Kosalec I, Basic I. Synergystic antitumor effect of polyphenolic components of water soluble derivative of propolis against Ehrlich ascites tumour. Biological and Pharmaceutical Bulletin 2005;28:694-700. (Pubitemid 40879940)
160. Mertens-Talcott S, Talcott S, Percival S. Low concentrations of quercetin and ellagic acid synergistically influence proliferation, cytotoxicity and apoptosis in MOLT-4 human leukemia cells. Journal of Nutrition 2003;133:2669-74. (Pubitemid 36935989)
161. Zamin L, Filippi-Chiela E, Dillenburg-Pilla P, Horn F, Salbego C, Lenz G. Resveratrol and quercetin cooperate to induce senescence-like growth arrest in C6 rat glioma cells. Cancer Science 2009;100:1655-62.
162. Shen F, Weber G. Synergistic action of quercetin and genistein in human ovarian carcinoma cells. Oncology Research 1997;9:597-602. (Pubitemid 127787910)
163. Knowles L, Zigrossi D, Tauber R, Hightower C, Milner J. Flavonoids suppress androgen-independent human prostate tumor proliferation. Nutrition and Cancer 2000;38:116-22. (Pubitemid 32377951)
164. Sharma H, Sen S, Singh N. Molecular pathways in the chemosensitization of cisplatin by quercetin in human head and neck cancer. Cancer Biology and Therapy 2005;4:949-55. (Pubitemid 41598589)
165. Jakubowicz-Gil J, Paduch R, Piersiak T, Glowniak K, Gawron A, Kandefer-Szerszen M. The effect of quercetin on pro-apoptotic activity of cisplatin in HeLa cells. Biochemical Pharmacology 2005;69:1343-50.
166. Cipak L, Rauko P, Miadokova E, Cipakova I, Novotny L. Effects of flavonoids on cisplatin-induced apoptosis of HL-60 and L1210 leukemia cells. Leukemia Research 2003;27:65-72. (Pubitemid 35449718)
167. Yeh Y, Herenyiova M, Weber G. Quercetin: synergistic action with carboxyamidotriazole in human breast carcinoma cells. Life Sciences 1995;57:1285-92.
168. Scambia G, Ranelletti F, Benedetti Panici P, de Vincenzo R, Bonanno G, Ferrandina G, et al. Quercetin potentiates the effect of adriamycin in a multidrug resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemotherapy and Pharmacology 1994;34:459-64. (Pubitemid 24306043)
169. Teofili L, Pierelli L, Lovino M, Leone G, Scambia G, De Vincenzo R, et al. The combination of quercetin and cytosine arabinoside synergistically inhibits leukemic cell growth. Leukemia Research 1992;16:497-503.
170. Cipák L, Berczeliová E, Paulíková H. Effects of flavonoids on glutathione and glutathione-related enzymes in cisplatin-treated L1210 leukemia cells. Neoplasma 2003;50:443-6. (Pubitemid 38009586)
171. Shen F, Herenyiova M, Weber G. Synergistic down-regulation of signal transduction and cytotoxicity by tiazofurin and quercetin in human ovarian carcinoma cells. Life Sciences 1999;64:1869-76. (Pubitemid 29215188)
172. Li W, Shen F, Weber G. Ribavirin and quercetin synergistically downregulate signal transduction and are cytotoxic in human ovarian carcinoma cells. Oncology Research 1999;11:243-7.
173. Ma Z, Nguyen T, Huynh T, Do P, Huynh H. Reduction of rat prostate weight by combined quercetin-finasteride treatment is associated with cell cycle deregulation. Journal of Endocrinology 2004;181:493-507. (Pubitemid 38868199)
174. Schlachterman A, Valle F, Wall K, Azios N, Castillo L, Morell L, et al. Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model. Translational Oncology 2008;1:19-27.